Xortx Therapeutics Stock Buy Hold or Sell Recommendation
| XRTX Stock | USD 1.27 0.06 4.96% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding XORTX Therapeutics is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell XORTX Therapeutics given historical horizon and risk tolerance towards XORTX Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for XORTX Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out XORTX Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide. In addition, we conduct extensive research on individual companies such as XORTX and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards XORTX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
XORTX |
Execute XORTX Therapeutics Buy or Sell Advice
The XORTX recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on XORTX Therapeutics. Macroaxis does not own or have any residual interests in XORTX Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute XORTX Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
XORTX Therapeutics Trading Alerts and Improvement Suggestions
| XORTX Therapeutics generated a negative expected return over the last 90 days | |
| XORTX Therapeutics has high historical volatility and very poor performance | |
| XORTX Therapeutics may become a speculative penny stock | |
| Net Loss for the year was (2.16 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| XORTX Therapeutics currently holds about 13.42 M in cash with (6.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.03. | |
| XORTX Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from seekingalpha.com: XORTX Therapeutics files to sell 810,810 common shares for holders |
XORTX Therapeutics Returns Distribution Density
The distribution of XORTX Therapeutics' historical returns is an attempt to chart the uncertainty of XORTX Therapeutics' future price movements. The chart of the probability distribution of XORTX Therapeutics daily returns describes the distribution of returns around its average expected value. We use XORTX Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of XORTX Therapeutics returns is essential to provide solid investment advice for XORTX Therapeutics.
| Mean Return | 1.17 | Value At Risk | -11.11 | Potential Upside | 16.04 | Standard Deviation | 18.24 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of XORTX Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
XORTX Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as XORTX Therapeutics, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading XORTX Therapeutics back and forth among themselves.
| Shares | Royal Bank Of Canada | 2024-06-30 | 1.2 K | Advisor Group Holdings, Inc. | 2024-06-30 | 1.2 K | Hartland & Co | 2024-06-30 | 277 | Jpmorgan Chase & Co | 2024-06-30 | 254 | Bank Of Montreal | 2024-06-30 | 0.0 | Bmo Capital Markets Corp. | 2024-06-30 | 0.0 | Citadel Advisors Llc | 2024-09-30 | 0.0 |
XORTX Therapeutics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (201.4K) | 112.7K | 14.7M | (3.5M) | (7.0M) | (6.6M) | |
| Free Cash Flow | (256.6K) | (742.8K) | (4.8M) | (8.9M) | (6.6M) | (6.3M) | |
| Capital Expenditures | 7.0K | 14.4K | 31.2K | 44.2K | 46.4K | 30.7K | |
| Net Income | (629.6K) | (1.3M) | (1.3M) | (7.0M) | (2.2M) | (2.3M) | |
| End Period Cash Flow | 58.6K | 171.3K | 14.8M | 10.4M | 3.4M | 3.6M | |
| Depreciation | 19.9K | 20.4K | 14.0K | 55.5K | 139.7K | 146.7K | |
| Other Non Cash Items | 1.6K | (90.2K) | 58.8K | 3.7K | (3.7M) | (3.5M) | |
| Investments | (7.0K) | (14.4K) | (39.8K) | (44.2K) | (46.4K) | (48.7K) | |
| Change To Netincome | 62.0K | 173.5K | (3.1M) | (4.5M) | (4.1M) | (3.9M) |
XORTX Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to XORTX Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that XORTX Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a XORTX stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.89 | |
β | Beta against Dow Jones | 2.17 | |
σ | Overall volatility | 6.91 | |
Ir | Information ratio | 0.06 |
XORTX Therapeutics Volatility Alert
XORTX Therapeutics is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure XORTX Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact XORTX Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.XORTX Therapeutics Fundamentals Vs Peers
Comparing XORTX Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze XORTX Therapeutics' direct or indirect competition across all of the common fundamentals between XORTX Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as XORTX Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of XORTX Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing XORTX Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare XORTX Therapeutics to competition |
| Fundamentals | XORTX Therapeutics | Peer Average |
| Return On Equity | -0.29 | -0.31 |
| Return On Asset | -0.33 | -0.14 |
| Current Valuation | 2.11 M | 16.62 B |
| Shares Outstanding | 3.22 M | 571.82 M |
| Shares Owned By Insiders | 3.01 % | 10.09 % |
| Shares Owned By Institutions | 6.03 % | 39.21 % |
| Number Of Shares Shorted | 3.74 K | 4.71 M |
| Price To Earning | 170.67 X | 28.72 X |
| Price To Book | 1.92 X | 9.51 X |
| EBITDA | (6.47 M) | 3.9 B |
| Net Income | (2.16 M) | 570.98 M |
| Cash And Equivalents | 13.42 M | 2.7 B |
| Cash Per Share | 1.03 X | 5.01 X |
| Total Debt | 11.51 K | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 14.09 X | 2.16 X |
| Book Value Per Share | 2.32 X | 1.93 K |
| Cash Flow From Operations | (6.58 M) | 971.22 M |
| Short Ratio | 0.02 X | 4.00 X |
| Earnings Per Share | 0.12 X | 3.12 X |
| Price To Earnings To Growth | 9.08 X | 4.89 X |
| Target Price | 12.17 | |
| Number Of Employees | 2 | 18.84 K |
| Beta | -0.21 | -0.15 |
| Market Capitalization | 4.34 M | 19.03 B |
| Total Asset | 5.47 M | 29.47 B |
| Retained Earnings | (17.85 M) | 9.33 B |
| Working Capital | 3.77 M | 1.48 B |
| Current Asset | 341.74 M | 9.34 B |
| Current Liabilities | 109.37 M | 7.9 B |
| Net Asset | 5.47 M |
XORTX Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as XORTX . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About XORTX Therapeutics Buy or Sell Advice
When is the right time to buy or sell XORTX Therapeutics? Buying financial instruments such as XORTX Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having XORTX Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run ESG Investing Thematic Idea Now
ESG Investing
Sustainable investments that promote the conservation of the natural world, social resposibility, freindly employees policies and strong governance. The ESG Investing theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize ESG Investing Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for XORTX Stock Analysis
When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.